Cancer therapy, whether it be radiation, chemotherapy, immunotherapy or targeted therapy, has improved patient survival rates and increased the overall cure rate. These treatments have made tremendous leaps and bounds in the quest to cure cancer, but they are not without their complications. They can sometimes cause problems in the heart and vascular system - called cardiotoxicity. Cardiac side effects can develop before or after cancer treatment, and can cause long-term heart damage and can often be fatal.
The cardio-oncology team treats patients who are at high risk for heart complications as well as those who have a history of heart disease. Utilizing a collaborative approach to personalized care, our expert team reduces and manages the risks of treatment-related cardiac toxicities.
Any cancer therapy that affects cardiac safety requires precise monitoring. Cancer complications include:
Patients, who experience symptoms associated with these cardiovascular complications during cancer therapy, undergo early investigation and diagnosis. This may include:
Treatment for cardiac complications caused by cancer therapies can be prevented via:
Additionally, we evaluate, diagnose and treat cardiac toxicities related to cancer treatments, and use the process of risk stratification to minimize the risk of cardiovascular complications, which involves identifying the right level of care and services for distinct subgroups of patients. Moreover, we:
Care of the Critically Ill Surgical Patient (CCrISP) is a two-day, interactive course, which includes mandatory, pre-course e-learning. It covers the practical skills and knowledge that health care professionals need to effectively care for surgical patients, including those who are deteriorating or at risk of doing so.